Hypersomnia

Dialogues in Clinical Neuroscience

Volumn 7, Issue 4, 2005, Pages 347-356

  Dauvilliers, Yves ^a   Buguet, Alain ^b  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Human African trypanosomiasis; Idiopathic hypersomnia; Infectious disease; Insufficient sleep syndrome; Narcolepsy; Periodic limb movements in sleep; Recurrent hypersomnia; Sleep apnea syndrome

Indexed keywords

AFRICAN TRYPANOSOMIASIS; ARTICLE; BACTERIAL INFECTION; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; ENDOCRINE DISEASE; HUMAN; HYPERSOMNIA; IDIOPATHIC DISEASE; MAINTENANCE OF WAKEFULNESS TEST; MENTAL DISEASE; METABOLIC DISORDER; MULTIPLE SLEEP LATENCY TEST; NARCOLEPSY; OSLER TEST; OXFORD SLEEP RESISTANCE TEST; PARASITOSIS; POLYSOMNOGRAPHY; PSYCHOMOTOR PERFORMANCE; PSYCHOMOTOR VIGILANCE TASK; QUESTIONNAIRE; RECURRENT DISEASE; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP WAKING CYCLE; SOMNOLENCE; VIRUS INFECTION;

CIRCADIAN RHYTHM; DISORDERS OF EXCESSIVE SOMNOLENCE; HUMANS; HYPERSOMNOLENCE, IDIOPATHIC; INFECTION; MENTAL DISORDERS; METABOLIC DISEASES; NARCOLEPSY; NERVOUS SYSTEM DISEASES; TOXINS, BIOLOGICAL;

EID: 30944455757     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Gélineau J. De la narcolepsie. Gaz Hôp Paris. 1880;55:626-628 and 635-637.
2. Billiard M. Hypersomnias. In: Billiard M, ed. Sleep: Physiology, Investigations and Medicine. New York, NY: Kluwer Academic/Plenum Publishers; 2003:333-336.
3. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Ann Rev Med. 1976;27:465-484.
4. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness. Psychophysiology. 1973;10:431-436.
5. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-545.
6. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, Calif: Brain Information Service/Brain Research Institute; 1968.
7. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the Multiple Sleep Latency test (MSLT): a standard measure of sleepiness. Sleep. 1986;9:519-524.
8. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 2nd Edition: Diagnostic and Coding Manual. Westchester, Ill: American Academy of Sleep Medicine; 2005.
9. Besset A. Assessing sleepiness. In: Billiard M, ed. Sleep: Physiology, Investigations and Medicine. New York, NY: Kluwer Academic/Plenum Publishers; 2003:169-184.
10. Billiard M, Dauvilliers Y. Narcolepsy. In: Billiard M, ed. Sleep: Physiology, Investigations and Medicine. New York, NY: Kluwer Academic/Plenum Publishers; 2003:403-406.
11. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 2000;68:686-699.
12. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59:1553-1562.
13. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6:991-997.
14. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27:469-474.
15. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98:365-376.
16. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 2000;54:1166-1175.
17. Carlander B. Traitements de la narcolepsie et autres troubles primaires de l'éveil. In: Billiard M, ed. Le sommeil normal et pathologique. 2nd ed. Paris, France: Masson; 1998:313-320.
18. Lockrane B, Bhatia P, Gore R. Successful treatment of narcolepsy and cataplexy: a review. Can Respir J. 2005;12:225-227.
19. Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol. 2004;56:905-908.
20. Billiard M, Dauvilliers Y. Idiopathic hypersomnia. Sleep Med Rev. 2001;5:351-360.
21. Roth B, Nevsimalova S, Rechtschaffen A. Hypersomnia with "sleep drunkenness." Arch Gen Psychiat. 1972;26:456-462.
22. Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology. 1996;46:393-401.
23. Broughton R, Nevsimalova S, Roth B. The socioeconomic effects (including work, education, recreation, and accidents) of idiopathic hypersomnia. Sleep Res. 1978;7:217.
24. Dauvilliers Y, Mayer G, Lecendreux M, et al. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002;59:1739-1745.
25. Bamford CR. Menstrual-associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. Sleep. 1993;16:484-486.
26. Chung KF. Recurrent hypersomnia: a case report with polysomnographic findings. Hong Kong Med J. 1997;3:107-110.
27. Carskadon MA, Dement WC. Cumulative effects of sleep restriction on daytime sleepiness. Psychophysiology. 1981;18:107-113.
28. Roehrs T, Roth T. Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev. 2001;5:287-297.
29. Drummond SPA, Gillin JC, Smith TL, DeModena A. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res. 1998;22:1796-1802.
30. Brower KJ, Aldrich MS, Hall JM. Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res. 1998;22:1864-1871.
31. Berger RJ, Oswald I. Effects of sleep deprivation on behaviour, subsequent sleep, and dreaming. J Ment Sci. 1962;108:457-465.
32. Buguet A, Montmayeur A, Pigeau R, Naitoh P. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. II. Effects on two recovery nights of recovery sleep. J Sleep Res. 1995;4:229-241.
33. Buguet A. Exploration du sommeil chez l'adulte et l'adolescent. Encycl Med Chir (Elsevier, Paris). Psychiatrie. 1994:37-680-A-04.
34. Billiard M, Dolenc L, Aldaz C, Ondze B, Besset A. Hypersomnia associated with mood disorders: a new perspective. J Psychosom Res. 1994;38:41-47.
35. Lingjaerde O, Bratlid T, Hansen T, Gotestam KG. Seasonal affective disorder and midwinter insomnia in the far north: studies on two chronobiological disorders in Norway. Clin Neuropharmacol. 1986;9:187-189.
36. Autret A, Lucas B, Mondon K, et al. Sleep and brain lesions: a critical review of the literature and additional new cases. Neurophysiol Clin. 2001;31:356-375.
37. Guilleminault C, Quera-Salva MA, Goldberg MP. Pseudo-hypersomnia and pre-sleep behaviour with bilateral paramedian thalamic lesions. Brain. 1993;116:1549-1563.
38. Gibbs JW 3rd, Ciafaloni E, Radtke RA. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep. 2002;25:672-675.
39. Guilleminault C, Yuen KM, Gulevich MG, Karadeniz D, Leger D, Philip P. Hypersomnia after head-neck trauma: a methodological dilemma. Neurology. 2000;54:653-659.
40. von Economo C. Grippe, Encephalitis und Encephalitis lethargica. Klin Wochens Wien. 1919;32:393-396.
41. Krueger JM, Majde JA. Humoral links between sleep and the immune system. Ann N Y Acad Sci. 2003;992:9-20.
42. Opp MR, Toth LA. Neural-immune interactions in the regulation of sleep. Front Biosci. 2003;8:768-779.
43. Voderholzer U, Riemann D, Gann H, et al. Transient total sleep loss in cerebral Whipple's disease: a longitudinal study. J Sleep Res. 2002;11:321-329.
44. Wiegand M, Möller AA, Schreiber W, et al. Nocturnal sleep EEG in patients with HIV infection. Eur Arch Psychiatr Clin Neurosci. 1991;240:153-158.
45. Buguet A, Bisser S, Josenando T, Chapotot F, Cespuglio R. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness. Acta Trop. 2005;93:107-117.
46. Buguet A, Bourdon L, Bouteille B, et al. The duality of sleeping sickness: focusing on sleep. Sleep Med Rev. 2001;5:139-153.
47. Perks WH, Horrocks PM, Cooper RA, et al. Sleep apnea in acromegaly. BMJ. 1980;280:894-897.
48. Montplaisir J, Gobout R, Poirier G, Bédard MA. Restless legs syndrome and periodic movements during sleep: electrophysiological, biochemical, and pharmacological study. Neurology. 1985;35:130-134.
49. Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004;27:560-583.
50. Hening WA. Restless legs syndrome: the most common and least diagnosed sleep disorder. Sleep Med. 2004;5:429-430.
51. Hening WA. Subjective and objective criteria in the diagnosis of the restless legs syndrome. Sleep Med. 2004;5:285-292.
52. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine report. Sleep. 2004;27:557-559.
53. Krieger J. Obstructive sleep apnoea-hypopnea syndrome and upper airway resistance syndrome. In: Billiard M, ed. Sleep: Physiology, Investigations and Medicine. New York, NY: Kluwer Academic/Plenum Publishers; 2003:357-389.
54. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1:862-865.
55. Crampette L. Surgical and prosthetic treatment for sleep apnoea syndrome and upper airway resistance syndrome. In: Billiard M, ed. Sleep: Physiology, Investigations and Medicine. New York, NY: Kluwer Academic/ Plenum Publishers; 2003:391-401.